Literature DB >> 24210758

Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analyses.

Jeanine F Amacher1, Patrick R Cushing1, Lionel Brooks2, Prisca Boisguerin3, Dean R Madden4.   

Abstract

PDZ domain interactions are involved in signaling and trafficking pathways that coordinate crucial cellular processes. Alignment-based PDZ binding motifs identify the few most favorable residues at certain positions along the peptide backbone. However, sequences that bind the CAL (CFTR-associated ligand) PDZ domain reveal only a degenerate motif that overpredicts the true number of high-affinity interactors. Here, we combine extended peptide-array motif analysis with biochemical techniques to show that non-motif "modulator" residues influence CAL binding. The crystallographic structures of 13 CAL:peptide complexes reveal defined, but accommodating stereochemical environments at non-motif positions, which are reflected in modulator preferences uncovered by multisequence substitutional arrays. These preferences facilitate the identification of high-affinity CAL binding sequences and differentially affect CAL and NHERF PDZ binding. As a result, they also help determine the specificity of a PDZ domain network that regulates the trafficking of CFTR at the apical membrane.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24210758      PMCID: PMC3947174          DOI: 10.1016/j.str.2013.09.019

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  47 in total

1.  Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.

Authors:  Urs Wiedemann; Prisca Boisguerin; Rainer Leben; Dietmar Leitner; Gerd Krause; Karin Moelling; Rudolf Volkmer-Engert; Hartmut Oschkinat
Journal:  J Mol Biol       Date:  2004-10-22       Impact factor: 5.469

Review 2.  The emerging contribution of sequence context to the specificity of protein interactions mediated by PDZ domains.

Authors:  Katja Luck; Sebastian Charbonnier; Gilles Travé
Journal:  FEBS Lett       Date:  2012-04-04       Impact factor: 4.124

3.  Peptides targeting the PDZ domain of PTPN4 are efficient inducers of glioblastoma cell death.

Authors:  Nicolas Babault; Florence Cordier; Mireille Lafage; Joseph Cockburn; Ahmed Haouz; Christophe Prehaud; Félix A Rey; Muriel Delepierre; Henri Buc; Monique Lafon; Nicolas Wolff
Journal:  Structure       Date:  2011-10-12       Impact factor: 5.006

4.  Rapid evolution of functional complexity in a domain family.

Authors:  Andreas Ernst; Stephen L Sazinsky; Shirley Hui; Bridget Currell; Moyez Dharsee; Somasekar Seshagiri; Gary D Bader; Sachdev S Sidhu
Journal:  Sci Signal       Date:  2009-09-08       Impact factor: 8.192

5.  Evolving specificity from variability for protein interaction domains.

Authors:  Tomonori Kaneko; Sachdev S Sidhu; Shawn S C Li
Journal:  Trends Biochem Sci       Date:  2011-01-10       Impact factor: 13.807

6.  Crystallization and preliminary diffraction analysis of the CAL PDZ domain in complex with a selective peptide inhibitor.

Authors:  Jeanine F Amacher; Patrick R Cushing; Joshua A Weiner; Dean R Madden
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-04-28

7.  A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression.

Authors:  Jie Cheng; Bryan D Moyer; Michal Milewski; Johannes Loffing; Masahiro Ikeda; John E Mickle; Garry R Cutting; Min Li; Bruce A Stanton; William B Guggino
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

8.  The spatial architecture of protein function and adaptation.

Authors:  Richard N McLaughlin; Frank J Poelwijk; Arjun Raman; Walraj S Gosal; Rama Ranganathan
Journal:  Nature       Date:  2012-10-07       Impact factor: 49.962

9.  The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.

Authors:  Patrick R Cushing; Abigail Fellows; Daniel Villone; Prisca Boisguérin; Dean R Madden
Journal:  Biochemistry       Date:  2008-08-29       Impact factor: 3.162

10.  Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.

Authors:  André Mischo; Oliver Ohlenschläger; Peter Hortschansky; Ramadurai Ramachandran; Matthias Görlach
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more
  14 in total

1.  A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45.

Authors:  Adam H Courtney; Jeanine F Amacher; Theresa A Kadlecek; Marianne N Mollenauer; Byron B Au-Yeung; John Kuriyan; Arthur Weiss
Journal:  Mol Cell       Date:  2017-07-20       Impact factor: 17.970

Review 2.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

3.  Intracellular Delivery of Peptidyl Ligands by Reversible Cyclization: Discovery of a PDZ Domain Inhibitor that Rescues CFTR Activity.

Authors:  Ziqing Qian; Xiaohua Xu; Jeanine F Amacher; Dean R Madden; Estelle Cormet-Boyaka; Dehua Pei
Journal:  Angew Chem Int Ed Engl       Date:  2015-03-17       Impact factor: 15.336

4.  Computational Analysis of Energy Landscapes Reveals Dynamic Features That Contribute to Binding of Inhibitors to CFTR-Associated Ligand.

Authors:  Graham T Holt; Jonathan D Jou; Nicholas P Gill; Anna U Lowegard; Jeffrey W Martin; Dean R Madden; Bruce R Donald
Journal:  J Phys Chem B       Date:  2019-11-27       Impact factor: 2.991

5.  MotifAnalyzer-PDZ: A computational program to investigate the evolution of PDZ-binding target specificity.

Authors:  Jordan Valgardson; Robin Cosbey; Paul Houser; Milo Rupp; Raiden Van Bronkhorst; Michael Lee; Filip Jagodzinski; Jeanine F Amacher
Journal:  Protein Sci       Date:  2019-11-01       Impact factor: 6.725

6.  Optimization of the process of inverted peptides (PIPEPLUS) to screen PDZ domain ligands.

Authors:  Quentin Seisel; Marisa Rädisch; Nicholas P Gill; Dean R Madden; Prisca Boisguerin
Journal:  Bioorg Med Chem Lett       Date:  2017-05-15       Impact factor: 2.823

7.  Structural and biochemical analysis of the PTPN4 PDZ domain bound to the C-terminal tail of the human papillomavirus E6 oncoprotein.

Authors:  Hye Seon Lee; Hye-Yeoung Yun; Eun-Woo Lee; Ho-Chul Shin; Seung Jun Kim; Bonsu Ku
Journal:  J Microbiol       Date:  2022-01-28       Impact factor: 2.902

8.  Structural characterization and computational analysis of PDZ domains in Monosiga brevicollis.

Authors:  Melody Gao; Iain G P Mackley; Samaneh Mesbahi-Vasey; Haley A Bamonte; Sarah A Struyvenberg; Louisa Landolt; Nick J Pederson; Lucy I Williams; Christopher D Bahl; Lionel Brooks; Jeanine F Amacher
Journal:  Protein Sci       Date:  2020-09-25       Impact factor: 6.725

9.  Cyclic Peptidyl Inhibitors against CAL/CFTR Interaction for Treatment of Cystic Fibrosis.

Authors:  Patrick G Dougherty; Jack H Wellmerling; Amritendu Koley; Jessica K Lukowski; Amanda B Hummon; Estelle Cormet-Boyaka; Dehua Pei
Journal:  J Med Chem       Date:  2020-12-14       Impact factor: 7.446

10.  Canonical and Noncanonical Sites Determine NPT2A Binding Selectivity to NHERF1 PDZ1.

Authors:  Tatyana Mamonova; Qiangmin Zhang; Jahan Ali Khajeh; Zimei Bu; Alessandro Bisello; Peter A Friedman
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.